scispace - formally typeset
A

Achintya D. Singh

Researcher at Cleveland Clinic

Publications -  59
Citations -  665

Achintya D. Singh is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 40 publications receiving 228 citations. Previous affiliations of Achintya D. Singh include All India Institute of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India.

TL;DR: The guidelines provide recommendations on three priority areas for EPTB: use of Xpert MTB/RIF in diagnosis, use of adjunct corticosteroids in treatment, and duration of treatment, which are complementary to the existing country standards of TB care and technical operational guidelines for pulmonary TB.
Journal ArticleDOI

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

Khanh Bao Tran, +1018 more
- 01 Aug 2022 - 
TL;DR: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019.
Journal ArticleDOI

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Brittney S. Sheena, +440 more
TL;DR: The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of hepatitis B vaccination, andHBV-related death rates also decreased, but HBV- related death counts increased as a result of population growth, ageing, and cohort effects.
Journal ArticleDOI

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Rajesh Sharma, +403 more
TL;DR: The increase in incidence rates in people younger than 50 years and the fast-rising burden in low SDI and middle SDI countries in Asia and Africa calls for colorectal cancer prevention approaches, greater awareness, and cost-effective screening and therapeutic options in these regions.
Journal ArticleDOI

A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.

TL;DR: None of the patients in either group developed procedure-related bleeding complications until 5 days post-procedure, and the complication rates at 28-day follow-up were similar between the groups.